Literature DB >> 23715581

Severe refractory scarring alopecia associated with combinational use of ficlatuzumab (AV-299) and gefitinib.

Yi-Hsien Shih1, Pin-Chun Chen, Chia-Yu Chu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23715581     DOI: 10.1200/JCO.2012.46.9346

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

Review 1.  Epigenetic editing and tumor-dependent immunosuppressive signaling in head and neck malignancies.

Authors:  Spyridon Gougousis; Savvas Petanidis; Alexandros Poutoglidis; Nikolaos Tsetsos; Paraskevas Vrochidis; Ioannis Skoumpas; Nektarios Argyriou; Theodora Katopodi; Kalliopi Domvri
Journal:  Oncol Lett       Date:  2022-05-04       Impact factor: 3.111

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.